REG - OptiBiotix Health - Notice of Results <Origin Href="QuoteRef">OPTIO.L</Origin>

OptiBiotix HealthAnnouncement

23/03/2016 08:17

RNS Number : 9494S
OptiBiotix Health PLC
23 March 2016
23 March 2016
OptiBiotix Health Plc
Notice of Results
Analyst Briefing
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its preliminary results for the year ended 30 November 2015 on Thursday 14 April 2016. 
A briefing for analysts will take place in the Gresham room at the London Capital Club, 15 Abchurch Lane, London EC4N 7BW at 9.30am on Thursday 14 April 2016. 
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or emailoptibiotix@walbrookpr.com.
For further information:
OptiBiotix Health plc
www.optibiotix.com
Stephen O'Hara, Chief Executive
Contact via Walbrook below


Cairn Financial Advisers LLP
Tel: 020 7148 7900
Liam Murray / Avi Robinson



Hybridan LLP (Joint Broker)
Claire Louise Noyce
 Tel: 020 3764 2341


Peterhouse Corporate Finance Ltd (Joint Broker)
Tel: 020 7469 0936
Duncan Vasey / Lucy Williams 



Walbrook PR Ltd
Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy
Mob: 07876 741 001
Mike Wort
Mob: 07900 608 002

This information is provided by RNS
The company news service from the London Stock Exchange
  END
NORLLFFRVTIFFIR